172 related articles for article (PubMed ID: 19522518)
1. Antineoplastic agents. 454. Synthesis of the strong cancer cell growth inhibitors trans-dihydronarciclasine and 7-deoxy-trans-dihydronarciclasine (1a).
Pettit GR; Ducki S; Eastham SA; Melody N
J Nat Prod; 2009 Jul; 72(7):1279-82. PubMed ID: 19522518
[TBL] [Abstract][Full Text] [Related]
2. Isolation and structural modification of 7-deoxynarciclasine and 7-deoxy-trans-dihydronarciclasine.
Pettit GR; Eastham SA; Melody N; Orr B; Herald DL; McGregor J; Knight JC; Doubek DL; Pettit GR; Garner LC; Bell JA
J Nat Prod; 2006 Jan; 69(1):7-13. PubMed ID: 16441059
[TBL] [Abstract][Full Text] [Related]
3. Antineoplastic agents, 301. An investigation of the Amaryllidaceae genus Hymenocallis.
Pettit GR; Pettit GR; Groszek G; Backhaus RA; Doubek DL; Barr RJ; Meerow AW
J Nat Prod; 1995 May; 58(5):756-9. PubMed ID: 7623049
[TBL] [Abstract][Full Text] [Related]
4. Human cytochrome P450 liability studies of trans-dihydronarciclasine: a readily available, potent, and selective cancer cell growth inhibitor.
McNulty J; Thorat A; Vurgun N; Nair JJ; Makaji E; Crankshaw DJ; Holloway AC; Pandey S
J Nat Prod; 2011 Jan; 74(1):106-8. PubMed ID: 21105682
[TBL] [Abstract][Full Text] [Related]
5. Antineoplastic agents. 450. Synthesis of (+)-pancratistatin from (+)-narciclasine as relay(1a).
Pettit GR; Melody N; Herald DL
J Org Chem; 2001 Apr; 66(8):2583-7. PubMed ID: 11304174
[TBL] [Abstract][Full Text] [Related]
6. Total synthesis and biological evaluation of Amaryllidaceae alkaloids: narciclasine, ent-7-deoxypancratistatin, regioisomer of 7-deoxypancratistatin, 10b-epi-deoxypancratistatin, and truncated derivatives.
Hudlicky T; Rinner U; Gonzalez D; Akgun H; Schilling S; Siengalewicz P; Martinot TA; Pettit GR
J Org Chem; 2002 Dec; 67(25):8726-43. PubMed ID: 12467383
[TBL] [Abstract][Full Text] [Related]
7. Antineoplastic agents. 550. Synthesis of 10b(s)-epipancratistatin from (+)-narciclasine.
Pettit GR; Melody N; Herald DL; Knight JC; Chapuis JC
J Nat Prod; 2007 Mar; 70(3):417-22. PubMed ID: 17346078
[TBL] [Abstract][Full Text] [Related]
8. Antineoplastic agents, 294. Variations in the formation of pancratistatin and related isocarbostyrils in Hymenocallis littoralis.
Pettit GR; Pettit GR; Backhaus RA; Boettner FE
J Nat Prod; 1995 Jan; 58(1):37-43. PubMed ID: 7760076
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of Amaryllidaceae Constituents and Unnatural Derivatives.
Ghavre M; Froese J; Pour M; Hudlicky T
Angew Chem Int Ed Engl; 2016 May; 55(19):5642-91. PubMed ID: 26969844
[TBL] [Abstract][Full Text] [Related]
10. Total synthesis of (+)-trans-dihydronarciclasine utilizing asymmetric conjugate addition.
Yamada K; Mogi Y; Mohamed MA; Takasu K; Tomioka K
Org Lett; 2012 Dec; 14(23):5868-71. PubMed ID: 23145975
[TBL] [Abstract][Full Text] [Related]
11. Antineoplastic agents 500. Narcistatin.
Pettit GR; Melody N; Simpson M; Thompson M; Herald DL; Knight JC
J Nat Prod; 2003 Jan; 66(1):92-6. PubMed ID: 12542352
[TBL] [Abstract][Full Text] [Related]
12. Antineoplastic agents. 527. Synthesis of 7-deoxynarcistatin, 7-deoxy-trans-dihydronarcistatin, and trans-dihydronarcistatin 1(1).
Pettit GR; Melody N
J Nat Prod; 2005 Feb; 68(2):207-11. PubMed ID: 15730244
[TBL] [Abstract][Full Text] [Related]
13. A beta-carboline-1-one mimic of the anticancer Amaryllidaceae constituent pancratistatin: synthesis and biological evaluation.
Rinner U; Hudlicky T; Gordon H; Pettit GR
Angew Chem Int Ed Engl; 2004 Oct; 43(40):5342-6. PubMed ID: 15468184
[No Abstract] [Full Text] [Related]
14. The First Enantioselective Total Synthesis of (-)-trans-Dihydronarciclasine.
Varró G; Hegedűs L; Simon A; Balogh A; Grün A; Leveles I; Vértessy BG; Kádas I
J Nat Prod; 2017 Jun; 80(6):1909-1917. PubMed ID: 28581297
[TBL] [Abstract][Full Text] [Related]
15. Pseudolycorine
Katoch D; Kumar D; Padwad YS; Singh B; Sharma U
Nat Prod Res; 2020 Jul; 34(14):2051-2058. PubMed ID: 30784301
[TBL] [Abstract][Full Text] [Related]
16. Total synthesis of Amaryllidaceae pyrrolophenanthridinium alkaloids via the Ziegler-Ullmann reaction: tortuosine, criasbetaine, and ungeremine.
Stark LM; Lin XF; Flippin LA
J Org Chem; 2000 May; 65(10):3227-30. PubMed ID: 10814221
[No Abstract] [Full Text] [Related]
17. A formal [3+3]-annulation-based approach to pancratistatins: total synthesis of (±)-7-deoxy-pancratistatin and its 2-epi and 2,4-diepi analogues.
Nieto-García O; Lago-Santomé H; Cagide-Fagín F; Ortiz-Lara JC; Alonso R
Org Biomol Chem; 2012 Jan; 10(4):825-34. PubMed ID: 22130626
[TBL] [Abstract][Full Text] [Related]
18. Chemoenzymatic synthesis of Amaryllidaceae constituents and biological evaluation of their C-1 analogues. The next generation synthesis of 7-deoxypancratistatin and trans-dihydrolycoricidine.
Collins J; Rinner U; Moser M; Hudlicky T; Ghiviriga I; Romero AE; Kornienko A; Ma D; Griffin C; Pandey S
J Org Chem; 2010 May; 75(9):3069-84. PubMed ID: 20373760
[TBL] [Abstract][Full Text] [Related]
19. Palladium-catalyzed asymmetric allylic substitution of 2-arylcyclohexenol derivatives: asymmetric total syntheses of (+)-crinamine, (-)-haemanthidine, and (+)-pretazettine.
Nishimata T; Sato Y; Mori M
J Org Chem; 2004 Mar; 69(6):1837-43. PubMed ID: 15058926
[TBL] [Abstract][Full Text] [Related]
20. (±)-trans-Dihydronarciclasine and (±)-trans-dihydrolycoricidine analogues modified in their ring A: Evaluation of their anticancer activity and a SAR study.
Varró G; Pálchuber P; Pogrányi B; Simon A; Hegedűs L; Kádas I
Eur J Med Chem; 2019 Jul; 173():76-89. PubMed ID: 30986573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
